Kimelman & Baird’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.29K Hold
459
﹤0.01% 221
2026
Q1
$6.2K Sell
459
-620
-57% -$8.68K ﹤0.01% 224
2025
Q4
$13.4K Sell
1,079
-34
-3% -$367 ﹤0.01% 212
2025
Q3
$11K Sell
1,113
-148
-12% -$1.44K ﹤0.01% 239
2025
Q2
$11.3K Sell
1,261
-40
-3% -$338 ﹤0.01% 254
2025
Q1
$11.3K Hold
1,301
﹤0.01% 255
2024
Q4
$16.2K Hold
1,301
﹤0.01% 244
2024
Q3
$15.1K Hold
1,301
﹤0.01% 248
2024
Q2
$13.8K Buy
+1,301
New +$14.4K ﹤0.01% 254

Other funds holding VTRS

Kimelman & Baird's VTRS Position: Q2 2026 in Review

Kimelman & Baird held its Viatris (VTRS) position steady in Q2 2026 at 459 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #221.

Kimelman & Baird first reported a position in VTRS in Q2 2024 and has held it in 9 quarters since. The position peaked at $16.2K in Q4 2024. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Kimelman & Baird held 459 shares of Viatris worth $7.29K as of Q2 2026.
  • Kimelman & Baird left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Kimelman & Baird's portfolio in Q2 2026, its #221 holding.
  • Kimelman & Baird first reported a position in Viatris in Q2 2024 and has held it in 9 quarters since.
  • Kimelman & Baird's Viatris position peaked at $16.2K in Q4 2024.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.